Tom Schmidt, Managing Editor, IDG Strategic Marketing Services interviewed Dr. Jane Reed, Head of Life Science Strategy, Linguamatics, on how pharma and biotech companies use text analytics to reduce the time and cost of their clinical trials and get drugs to market faster.
The common statistic is that over 80% of data lies in unstructured text. Often, the way that people write things, whether in patents, healthcare records, or scientific literature, it's not easy to pull out the nuggets that are going to help with those decisions, whether around the real world value of your product, regulatory compliance, or many other different areas. Text analytics has to play a part in addressing many problems because of the volume of data that is unstructured.
Watch the full interview below.